publicações selecionadas
- Cyclooxygenase (COX)-2 modulates Toxoplasma gondii infection, immune response and lipid droplets formation in human trophoblast cells and villous explants
- Conhecimentos de gestantes e profissionais de saúde sobre toxoplasmose congênita
- Biogenic Silver Nanoparticles (AgNp-Bio) is able to control Toxoplasma gondii infection in human trophoblast cells and villous explants
- Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection
- Transforming growth factor (TGF)-β1 and interferon (IFN)-γ differentially regulate ICAM-1 expression and adhesion of Toxoplasma gondii to human trophoblast (BeWo) and uterine cervical (HeLa) cells
- Enrofloxacina e toltrazuril reduzem a infecção por Toxoplasma gondii em células trofoblásticas humanas e em explantes de vilos placentários humanos de terceiro trimestre
- Papel da molécula de adesão intercelular 1 (ICAM-1) na transmissão transplacentária de Toxoplasma gondii: estudos in vitro e in vivo
- ERK1/2 phosphorylation and IL-6 production are involved in the differential susceptibility to Toxoplasma gondii infection in three types of human (cyto/ syncytio/ extravillous) trophoblast cells
- BEWO TROPHOBLAST CELLS AND TOXOPLASMA GONDII INFECTION MODULATE CELL DEATH MECHANISMS IN THP-1 MONOCYTE CELLS BY INTERFERENCE IN THE EXPRESSION OF DEATH RECEPTOR AND INTRACELLULAR PROTEINS
- Mecanismos de transmissão transplacentária de Toxoplasma gondii em modelos murinos e em cultura de células
- LPS-mediated activation of TLR4 controls Toxoplasma gondii growth in human trophoblast cell (BeWo) and human villous explants in a dependent-manner of TRIF, MyD88, NF-κB and cytokines
- Predicted impacts of government policies and actions on the SARS-CoV-2 disease in the northwestern Himalayan region, India